Role of estradiol and progesterone in HIV susceptibility and disease progression

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 11, 2012, Pages 1049-1054

  Cabrera Munoz E ^a   Hernandez Hernandez O T ^b   Camacho Arroyo, I ^b  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

AIDS; Estradiol; HIV; Progesterone

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ESTRADIOL; ESTRADIOL RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; DISEASE COURSE; DISEASE PREDISPOSITION; HORMONE ACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; VIRUS LOAD;

ESTRADIOL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; PROGESTERONE;

EID: 84867003523     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712802762185     Document Type: Article

References (67)

1. Cabrera-Muñoz, E.; González-Arenas, A.; Saqui-Salces, M.; Camacho, J.; Larrea, F.; García-Becerra, R.; Camacho-Arroyo, I. Regulation of progesterone receptor isoforms content in human astrocytoma cell lines. J. Steroid Biochem. Mol. Biol., 2009, 113 (1-2), 80-84.
2. Camacho-Arroyo, I; Hernández-Molina, V. I.; Rivas-Suárez, M.; Guerra-Araiza, C.; González-Morán, M. G. Changes in progesterone receptor isoforms content in the brain of immature, mature and aged male and female chickens. Gen. Comp. Endocrinol., 2007, 150(3), 381-385.
3. Camacho-Arroyo, I.; Gonzalez-Arenas, A.; Gonzalez-Moran, G. Ontogenic variations in the content and distribution of progesterone receptor isoforms in the reproductive tract and brain of chicks. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 2007, 146(4), 644-652.
4. Straub, R. H. The complex role of estrogens in inflammation. Endocr. Rev., 2007, 28, 521-574.
5. Härkö nen, P. L.; Väänänen, H. K. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann. NY Acad. Sci., 2006, 1089, 218-227.
6. Salem, M. L.; Hossain, M. S.; Nomoto, K. Mediation of the immunomodulatory effect of α-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-α and IFNα. Int. Arch. Allergy Immunol., 2000, 121, 235-245.
7. Ito, A.; Buenafe, A. C.; Matejuk, A.; Zamora, A.; Silverman, M.; Dwyer, J.; Vandenbark, A. A.; Offner, H. Estrogen inhibits systemic T cell expression of TNF-α and recruitment of TNF-α T cells and macrophages into the CNS of mice developing experimental encephalomyelitis. Clin. Immunol., 2002, 102, 275-282.
8. Su, L.; Sun, Y.; Ma, F.; Lü, P.; Huang, H.; Zhou J. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol. Lett., 2009, 125(2), 151-155.
9. Butts, C. L.; Shukair, S. A.; Duncan, K. M.; Bowers, E.; Horn, C.; Belyavskaya, E.; Tonelli, L.; Sternberg, E. M. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int. Immunol., 2007, 19(3), 287-296.
10. Auerbach, L.; Hafner, T.; Huber, J. C.; Panzer, S. Influence of low dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. Fertil Steril., 2002, 78, 83-89.
11. Hunt, J. S.; Miller, L.; Platt, J. S. Hormonal regulation of uterine macrophages. Dev. Immunol., 1998, 6, 105-110.
12. Prakash, M.; Kapembwa, M.S.; Gotch, F.; Patterson, S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J. Reprod. Immunol., 2002, 54(1-2), 117-31.
13. Benki, S., McClelland, R. S.; Overbaugh, J. Risk factors for human immunodeficiency virus type-1 acquisition in women in Africa. J. Neurovirol., 2005, 11, 58-65.
14. Woolley, C.S.; McEwen B. S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol., 1993, 336(2), 293-306.
15. Caldwell, J.D.; Suleman, F.; Chou, S. H.; Shapiro, R. A.; Herbert, Z.; Jirikowski, G. F.Emerging roles of steroid-binding globulins. Horm. Metab. Res., 2006, 38(4). 206-218.
16. van Wingen, G.; van Broekhoven, F.; Verkes, R. J.; Petersson, K. M.; Bäckström, T.; Buitelaar, J.; Fernández, G., How progesterone impairs memory for biologically salient stimuli in healthy young women. J. Neurosci., 2007, 27(42), 11416-11423.
17. Camacho-Arroyo, I.; Rodriguez-Dorantes, M. Transcriptional activity regulates by progesterone receptor isoforms. In: Recent Research Developments in Life Sciences. Research Signpost. Ed.; Kerala, Gayathri A, 2006 pp. 25-38.
18. Bain, D. L.; Heneghan, A. F.; Connaghan-Jones, K.D.; Miura, M. T. Nuclear receptor structure: implications for function. Ann. Rev. Physiol., 2007, 69, 201-20.
19. Kastner, K.; Krust, A.; Turcotte, B.; Stropp, U.; Tora, L.; Gronemeyer, H.; Chambon, P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO 1990, 9, 1603-1614.
20. Tung, l.; Mohamed, M. K.; Hoeffler, J. P.; Takimoto, G. S.; Horowitz, K. B. Antagonist-occupied human progesterone Breceptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol., 1993, 7, 1256-1265.
21. MacGregor, J. I.; Jordan, V. C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 1998, 50(2), 151-96.
22. Delaunay, F.; Pettersson, K.; Tujague, M.; Gustafsson, J. A.; Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol. Pharmacol., 2000, 58(3), 584-90.
23. Faivre, E. J.; Daniel, A.R.; Hillard, C. J.; Lange, C. A. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol. Endocrinol., 2007, 21(12), 2890-906.
24. Nilsson, S.; Mäkelä, S.; Treuter, E.; Tujague, M.; Thomsen, J.; Andersson, G.; Enmark, E.; Pettersson, K.; Warner, M.; Gustafsson, J. A. Mechanisms of estrogen action. Physiol. Rev., 2001, 81(4), 1535-1565.
25. Thomas, P.; Tubbs, C.; Garry, V. F. Progestin functions in vertebrate gametes mediated by membrane progestin receptors (mPRs): Identification of mPRalpha on human sperm and its association with sperm motility. Steroids, 2009, 74(7), 614-621.
26. Zhu, Y.; Hanna, R. N.; Schaaf, M. J.; Spaink, H. P.; Thomas, P. Candidates for membrane progestin receptors--past approaches and future challenges. Comp. Biochem. Physiol. C Toxicol Pharmacol., 2008, 148(4), 381-389.
27. Thomas, P.; Pang, Y.; Filardo, E. J.; and Dong, J. Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells. Endocrinology, 2005, 146(2), 624-632.
28. Mizukami, Y. In Vivo Functions of GPR30/GPER-1, a Membrane receptor for estrogen: from discovery to functions in vivo. Endocrine J., 2010, 57 (2), 101-107.
29. Available from: http://www.unaids.org/globalreport/Global_report_es.htm
30. Collazos, J.; Asensi, V.; Carton J.A. Factors associated with poor immunologic responses despite viral suppression in markedly immunosuppressed patients. AIDS Patient Care STDS, 2007, 21(6), 378-384.
31. Farzadegan, H.; Hoover, D.R.; Astemborski, J.; Lyles, C. M.; Margolick, J. B.; Markham, R. B.; Quinn, T. C.; Vlahov, D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet, 1998, 352(9139), 1510-1514.
32. Sterling, T.R.; Pisell-Noland, T.; Perez, J. L.; Astemborski, J.; McGriff, J. R.; Nutting, L.; Hoover, D. R.; Vlahov, D.; Bollinger, R. C. Sex-based differences in T lymphocyte responses in HIV-1- seropositive individuals. J. Infect. Dis., 2005, 191(6), 881-885.
33. Smith, S. M.; Baskin, G.B.; Marx, P. A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis., 2000, 182(3), 708-715.
34. Heron, P. M.; Turchan-Cholewo, J.; Bruce-Keller, A. J.; Wilson, M. E. Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia. AIDS Res. Hum. Retroviruses, 2009, 25(11), 1071-1081.
35. Dolan, M.J.; Kulkarni, H.; Camargo, J. F.; He, W.; Smith, A.; Anaya, J. M.; Miura. T.; Hecht, F. M.; Mamtani, M.; Pereyra, F.; Marconi, V.; Mangano, A.; Sem, L.; Bologna, R.; Clark, R. A.; Anderson, S. A.; Delmar, J.; O'Connell, R. J.; Lloyd, A.; Martin, J.; Ahuja, S. S.; Agan, B.K.; Walker, B. D.; Deeks, S. G.; Ahuja, S. K. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat. Immunol., 2007, 8(12), 1324-1336
36. Dolan, S.E; Carpenter, S.; Grinspoon, S. Effects of weight, body composition, and testosterone on bone mineral density in HIVinfected women. J. Acquir. Immune Defic. Syndr., 2007, 45(2), 161-167.
37. Asin, S.N.; Heimberg, A. M.; Eszterhas, S. K.; Rollenhagen, C.; Howell, A. L. Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells. AIDS Res. Hum. Retroviruses, 2008, 24, 701-716.
38. Ellerbrock, T. V.; Wright, T. C.; Bush, T. J.; Dole, P.; Brudney, K.; Chiasson, M. A. Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet. Gynecol., 1996, 87, 1030-1034.
39. Cu-Uvin, S.; Wright, D. J.; Anderson, D.; Kovacs, A.; Watts, D. H.; Cohn, J.; Landay, A.; Reichelderfer, O. S. Hormonal levels among HIV-1-seropositive women compared with high-risk HIVseronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team. J. Women's Health Gend Based Med., 2000, 9(8), 857-863.
40. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ, 1992, 304, 809-813.
41. Aaby, P.; Ariyoshi, K.; Buckner, M.; Jensen, H.; Berry, N.; Wilkins, A.; Richard, D.; Larsen, O.; Dias, F.; Melbye, M. M.; Whittle, H. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. AIDS, 1996, 10, 1585-1590.
42. Stringer, E. M.; Levy, J.; Sinkala, M.; Chi, B. H.; Matongo, I.; Chintu, N.; Stringer, J. S. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS, 2009, 23(11), 1377-13782.
43. Smith, S. M.; Baskin, G. B.; Marx, P. A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J. Infect Dis., 2000, 182,708-715.
44. Smith, S M.; Mefford, M.; Sodora, D.; Klase, Z.; Singh, M.; Alexander, N.; Hess, D.; Marx, P. A. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS, 2004, 18, 1637-1643.
45. Molander, U.; Milsom, I.; Ekelund, P.; Mellström, D.; Eriksson, O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas, 1990, 12, 113-120.
46. Gupta, S.; Kumar, N.; Singhal, N.; Manektala, U.; Jain, S, Sodhani, P. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn. Cytopathol., 2006, 34, 676-681.
47. Sikoski, P.; Register, T. C.; Lees, C. J.; Lundeen, S.; Hutchison, J.; Brown, K. H.; Cline, J. M. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis). Am. J. Obstet. Gynecol., 2007, 196, 75-77.
48. Cline, J. M.; Register, T. C.; Clarkson, T. B. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys. Menopause, 2002, 9, 242-252.
49. Felding, C.; Mikkelsen, A. L.; Clausen, H. V.; Loft, A.; Larsen, L. G. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse.Arandomised, double-blind trial. Maturitas, 1992, 15, 241-249.
50. Marx, P.A.; Spira, A. I.; Gettie, A.; Dailey, P. J.; Veazey, R. S.; Lackner, A. A.; Mahoney, C. J.; Miller, C. J.; Claypool, L. E.; Ho, D. D.; Alexander, N. J. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med., 1996, 2,1084-1089.
51. Duh, E. J.; Maury, W. J.; Folks, T. M.; Fauci, A. S.; Rabson, A. B. Tumor necrosis factor a activates human immunodeficiency virus-1 through induction of nuclear factor binding to the NF-KB sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 5974-5978.
52. Heron, P. M.; Turchan-Cholewo J.; Bruce-Keller, J.; Wilson, M. E. Estrogen Receptor Alpha Inhibits the Estrogen-Mediated Suppression of HIV Transcription in Astrocytes: Implications for Estrogen Neuroprotection in HIV Dementia. AIDS Res. Hum. Retrov., 2009, 26(11), 1071-1081.
53. Freed, E. O. HIV-1 replication. Somat. Cell Mol. Genet., 2001, 26, 13-33.
54. Brigati, C.; Giacca, M.; Noonan, D.; and Albini, A. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol. Lett., 2003, 220 (1), 57-65.
55. Marcello, A.; Lusic, M.; Pegoraro, G.; Pellegrini, V.; Beltram, F.; and Giacca, M. Nuclear organization and the control of HIV-1 transcription. Gene, 2004, 326, 1-11.
56. Wilson, E. M.; Dimayuga, O. F.; Reed, L. J.; Curry, E. T.; Anderson, F. C.; Nath, A.; and Bruce-Keller J. A.; Immune Modulation by Estrogens. Endocrine, 2006, 29(2), 289-297.
57. Lee, Y. W.; Eum, Y. S.; Nath, A.; Toborek, M. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells. Cardiovasc Res., 2004, 63, 139-148.
58. Vassiliadou, N.; Tucker, L.; Anderson, D. J. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J. Immunol., 1999, 162(12), 7510-7518.
59. Carrington, M.; O'Brien, S.J. The influence of HLA genotype on AIDS. Ann. Rev. Med., 2003, 54, 535-551.
60. Gonzalez, E.; Bamshad, M.; Sato, N.; Mummidi, S.; Dhanda, R.; Catano, G.; Cabrera, S.; McBride, M.; Cao, X. H.; Merrill, G.; O'Connell, P.; Bowden, D. W.; Freedman, B. I.; Anderson, S. A.; Walter, E. A.; Evans, J. S.; Stephan, K. T.; Clark, R. A.; Tyagi, S.; Ahuja, S. S.; Dolan, M. J.; Ahuja, S. K. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc. Nat. Acad. Sci. U.S.A., 1999, 96(21), 12004-12009.
61. Dittmar, M.T.; McKnight, A.; Simmons, G.; Clapham, P. R.; Weiss, R. A.; Simmonds, P. HIV-1 tropism and co-receptor use. Nature, 1997, 385(6616), 495-496.
62. Dimitrov, A.S.; Rawat, S. S.; Jiang, S.; Blumenthal, R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry, 2003, 42(48), 14150-14158.
63. Berger, E.A.; Murphy, P. M.; Farber, J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Ann. Rev. Immunol., 1999, 657-700.
64. Chao, K.H.; Wu, M. Y.; Chen, M. J.; Hung, C.C.; Ho, H. N. Impact of the menstrual cycle on immunologic markers in HIV-infected Taiwanese women. Taiwan J. Obs. Gynecol., 2006, 45(1), 42-47.
65. Patterson, B.K.; Landay, A.; Andersson, J.; Brown, C.; Behbahani, H.; Jiyamapa, D.; Burki, Z.; Stanislawski, D.; Czerniewski, M. A.; Garcia, P. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am. J. Pathol., 1998, 153(2), 4814-90.
66. Yeaman, G.R.; Howell, A. L.; Weldon, S.; Demian, D. J.; Collins, J. E.; O'Connell, D. M.; Asin, S. N.; Wira, C. R.; Fanger, M. W. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology, 2003, 109(1),137-146.
67. Dosiou, C.; Hamilton, A. E.; Pang, Y.; Overgaard, M. T.; Tulac, S.; Dong, J.; Thomas, P.; Giudice, L. C. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J. Endocrinol., 2008, 196, 67-77.